PDT Partners’s Sana Biotechnology SANA Stock Holding History

PDT Partners’s Portfolio SANA Stock Details SANA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-54,453	Closed	-$545K	–	737
2024 Q1	$545K	Buy	+54,453	New	+$408K	0.05%	439
2023 Q4	–	Sell	-19,253	Closed	-$74.5K	–	655
2023 Q3	$74.5K	Sell	19,253 -7,674	-28%	-$41.2K	0.01%	562
2023 Q2	$160K	Sell	26,927 -25,485	-49%	-$147K	0.02%	517
2023 Q1	$171K	Sell	52,412 -101,623	-66%	-$406K	0.02%	510
2022 Q4	$608K	Buy	154,035 +54,376	+55%	+$266K	0.1%	343
2022 Q3	$598K	Sell	99,659 -52,076	-34%	-$376K	0.09%	383
2022 Q2	$976K	Hold	151,735	–	–	0.09%	400
2022 Q1	$1.25M	Buy	151,735 +94,730	+166%	+$766K	0.11%	300
2021 Q4	$882K	Sell	57,005 -16,613	-23%	-$320K	0.07%	399
2021 Q3	$1.66M	Buy	+73,618	New	+$1.55M	0.12%	271

Other funds holding SANA

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Crestline Management Fort Worth, Texas $53.5M AUM 80.67% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

PDT Partners's SANA Position: Q2 2024 in Review

PDT Partners sold out of Sana Biotechnology (SANA) in Q2 2024, closing a stake of 54,453 shares — an estimated $545K sold.

PDT Partners first reported a position in SANA in Q3 2021 and held it in 10 quarters. The position peaked at $1.66M in Q3 2021. 148 funds tracked by Wall St. Rank hold SANA as of Q2 2024.

PDT Partners reported no remaining Sana Biotechnology position as of Q2 2024 after selling out during the quarter.
PDT Partners sold 54,453 Sana Biotechnology shares in Q2 2024, an estimated $545K.
PDT Partners first reported a position in Sana Biotechnology in Q3 2021 and held it in 10 quarters.
PDT Partners's Sana Biotechnology position peaked at $1.66M in Q3 2021.
148 funds tracked by Wall St. Rank held Sana Biotechnology as of Q2 2024.

Based on PDT Partners's 13F filing for Q2 2024, filed 15 Aug 2024.